MANDATORY STATEMENTS

Botox®, Prescription Medicine For the treatment of frown lines and crow’s feet round the eyes Botox® has risks and benefits. Ask your doctor if Botox is right for you Botulinum toxin type A 50, 100, 200 Units. For product information check with your doctor or Consumer Medicine Information on www.medsafe.govt.nz Click for further details. Allergan, Auckland.

Dysport®, Prescription Medicine For the treatment of frown lines and crow’s feet round the eyes. Dysport® has risks and benefits. Ask your doctor if Dysport is right for you Botulinum toxin type A 300 or 500 Ipsen Units For product information check with your doctor or Consumer Medicine Information on www.medsafe.govt.nz . Click for further details Galderma, Auckland.

Restylane® is a natural cosmetic dermal filler that restores volume and fullness to the skin to smooth facial wrinkles and folds, enhance facial shape or to create fuller lips. Restylane® is available through prescription only from a medical professional, and is

delivered by injection into or below the skin. It is not to be injected into blood vessels as this may lead to a lack of blood supply to the skin and ulceration and scarring. Restylane® contains hyaluronic acid, naturally found in the human body and is thought

to help increase moisture in the skin. Treatment benefits are instant, do not affect facial expression and results usually last 6-12 months. Ongoing treatments are needed to maintain best results. After a Restylane® treatment you may expect some degree of

redness, swelling, pain or tenderness, itching and/or bruising which generally only lasts a few days. Inflammatory reactions may last up to two weeks in rare cases. Adverse effects from treatment are extremely rare and may include allergy, infection, granuloma

formation, persistent discoloration at the injection site, and/or ulceration of the skin. Exposure to sunlight should be avoided during the initial post treatment phase. Restylane® should not be used in or near sites where there are active skin disease,

inflammation or infection, or where a permanent implant has been placed. Restylane® is not recommended for people taking blood thinning medicines or Roaccutane for acne, and has not been tested in pregnant or breast-feeding women. Restylane® is

an unfunded Prescription medicine, and there will be a charge for the medicine and consultation. Ask you specialist if Restylane is right for you. Contains: Hyaluronic acid 20mg/ml phosphate buffered saline, pH 7 q.s. Q-Med Ltd, Auckland. Distributed by Healthcare Logistics, Auckland.

The JUVÉDERM® range of injectable gels are medical devices for use in adults. JUVÉDERM® VOLITE contain 12mg/mL cross-linked hyaluronic acid with lidocaine 3mg/mL. JUVÉDERM® ULTRA XC and JUVÉDERM® ULTRA PLUS XC contain 24mg/mL cross-linked hyaluronic acid with lidocaine 3mg/mL. Juvéderm® VOLITE™ is for filling superficial depressions of the skin as well as for additional improvement of skin quality attributes such as hydration and elasticity. JUVÉDERM® ULTRA XC is for filling medium-sized depressions of the skin as well as for lip definition. JUVÉDERM® ULTRA PLUS XC is for filling mid and/or deep depressions of the skin as well as for lip definition and enhancement. All JUVÉDERM® products should be administered only by a trained medical professional. JUVÉDERM® ULTRA XC and JUVÉDERM® ULTRA PLUS XC™ should not be injected into the eyelids. You should not receive treatment with any JUVÉDERM® product if you are below 18 years of age, have untreated epilepsy, history of hypertrophic scars or porphyria, or if you are pregnant or breastfeeding, hypersensitivity to ingredients including hyaluronic acid, lidocaine or amide-type local anaesthetics, any areas of cutaneous inflammation and/or infections, or if you have just had laser treatment, deep chemical peel or dermabrasion. Precautions: Caution is required if you have received treatment with another dermal filler; if you have a history of or are currently suffering an auto-immune disease, severe multiple allergies, anaphylactic shock, streptococcal disease, symptoms of cardiac conduction disorders; or if you are taking certain medications including anti-coagulants or certain drugs that reduce/inhibit hepatic metabolism. Avoid makeup for 12 hours after injection and prolonged exposure to sunlight/UV light/extreme temperatures for 2 weeks. Adverse effects reported after treatment with JUVÉDERM® range of fillers have included immediate or delayed injection site inflammatory reactions (redness/swelling/ itching/pain on pressure) persisting a week post treatment, haematomas, induration or nodules, discolouration, weak filling effect, risk of infection, abscess formation, granuloma, necrosis or hypersensitivity. Please ask your medical professional or request for the Directions For Use for complete list of precautions and adverse effects per respective filler. JUVÉDERM® injectable gels are not funded on the New Zealand Pharmaceutical Scheme. You will need to pay for this treatment. Normal visit fees apply. Speak to your medical professional about your own situation and about the benefits/ risks of this procedure in appearance medicine. If you have any side effects or concerns speak to your doctor.  ®Trademark(s) and registered trademark(s) of Allergan, Inc. Allergan Australia Pty Ltd. 810 Pacific Highway, Gordon NSW 2072. ABN 85 000 612 831. Allergan New Zealand Limited, Auckland. © 2018 Allergan. All rights reserved. Date of preparation: October 2018 ANZ/0104/2017.

Sunekos 1200 is an implantable medicaldevice thatmodifies the structure of matureskin, restoring volume, filling wrinkles and folds in the skin and in scar sites.It issuitablefor creating a temporary increase in the volume of skin tissue.Sunekos 1200is a medical device that is sterile, injectable, non-pyrogenic, biocompatible, re-absorbable, made with hyaluronic acid and amino acids.Sunekos Performa is a medical device recommended for the treatment of blemishesand depressions in the skin caused by wrinkles and scars. Sunekos Performa is asterileresorbable injectable solution which acts as a filler, supporting the restorationof physiological elasticity and temporarily replacing volume by expanding the softtissues.Sunekos should not be used on patients: with known hypersensitivity to any of itscomponents; presenting with a general infection, inflammatory or infectiouscutaneous problems; with history of severe multiple allergies or anaphylactic shock;prone to hypertrophic scars/keloids or streptococcal diseases; in patients presentingwith porphyria; under 18 years of age; in pregnancy or lactation; others. See fullInstructions for use before prescribing for full safety information,available fromwww.xytide.co.nzCopyright© 2024. Xytide Biotech Pty Ltd.Always read the label and follow theinstructions. This medical device must be administered by a Healthcare Professional.New Zealand Sponsor: AA-Med Pty LtdDistributed by:Xytide Biotech NZ Pty Ltd (NZBN 9429049668612) C/O Alliott Ltd, Level2, 142 Broadway, Newmarket, Auckland 1023 NZ. For more information please phone+61 1800 570 036